Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07628036
Starting soon Observational

Urinary Continence After Vaginal Surgery for Genital Prolapse in the Spanish Population.

NCT07628036 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Started
2026-08-01
Last updated
2026-06-04

Condition(s) studied

Pelvic Organ Prolapse (POP)Pelvic Organ Prolapse Vaginal SurgeryUrinary Incontinence (UI)

Investigational drug(s) / intervention(s)

Vaginal surgery for pelvic organ prolapse

Vaginal surgery for pelvic organ prolapse: Vaginal surgery of any vaginal compartment for pelvic organ prolapse

Study summary

Surgical correction of pelvic organ prolapse (POP) may be associated with the development of postoperative stress urinary incontinence (SUI). This clearly affects women's satisfaction and their quality of life, and may require subsequent medical and/or surgical treatments.

On the other hand, pre-existing SUI could resolve after corrective prolapse surgery. Similarly, urge urinary incontinence (UUI) could appear or improve after vaginal POP surgery. Therefore, it is of paramount importance to know the prevalence of urinary incontinence after POP vaginal surgery and incontinence resolution in our population. Identifying the risk factors for the development of urinary incontinence may allow to provide individualized treatment.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Women who will undergo vaginal surgery for pelvic organ prolapse Exclusion Criteria: * inhability to give consent to the study

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Vall d'Hebron Barcelona Hospital Campus Barcelona Barcelona
Fundació Hospital de l'Esperit Sant Santa Coloma de Gramenet Barcelona
Hospital Virgen de la Arrixaca Murcia Murcia
Complejo Universitario Insular, Hospital materno-infantil Las Palmas de Gran Canaria Tenerife

More Hospital Universitari Vall d'Hebron Research Institute trials in Spain

Integrative Diagnosis for SCD and Other RADs Recruiting
Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback Recruiting
Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation Recruiting
EARLY-SARDS: Early AlveolaR Lung biologY Underling Sepsis-Associated ARDS Starting soon
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) Recruiting

Other trials for the same condition

Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects Enrolling by invitation
Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate Cancer Enrolling by invitation
Pelvic Floor Muscle Training and Neuromuscular Performance in Women's Rugby Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07628036 on ClinicalTrials.gov ↗ ← All trials in Spain